Herbalife (NYSE:HLF) today announced the appointment of Richard
H. Carmona, M.D., M.P.H., FACS, and 17th Surgeon General of the
United States, to the Company’s Board of Directors, effective
October 25, 2013. Dr. Carmona brings more than 40 years of
experience in medicine, nutrition, preventative health and business
to the Herbalife Board.
DR. RICHARD H. CARMONA - 17th SURGEON
GENERAL OF THE UNITED STATES (2002-2006) (Photo: Business Wire)
Dr. Carmona joins as an independent Director. With his
appointment, Herbalife has increased the size of its Board to 12
members, 9 of whom are independent.
“As a scientist and medical professional, I was first attracted
by the depth and breadth of Herbalife’s commitment to excellence in
nutrition science,” said Carmona. “As a business person, my due
diligence showed me a company of integrity with a good business
plan. As the son of poor emigrant parents, I am elated to see the
opportunities Herbalife offers to families in health-disparate and
economically underserved communities.”
“Dr. Carmona has dedicated his life to improving the
relationships among health, culture, education and economic status,
and we are pleased to welcome him to Herbalife’s Board of
Directors,” said Michael O. Johnson, chairman and chief executive
officer of Herbalife. “As a Surgeon General of the United States, a
distinguished professor of public health, and an experienced
business leader, Richard will be a tremendous addition to our
Board. We look forward to leveraging his expertise in our ongoing
initiative to ensure the nutritional benefits of all Herbalife
products and our continued efforts to empower our distributors
around the world.”
About Dr. Richard H. Carmona
Dr. Carmona currently serves as the first Distinguished
Professor of Public Health at the University of Arizona, and the
first Distinguished Professor of Health Promotion and
Entrepreneurship at The Ohio State University. He is President of
the nonprofit Canyon Ranch Institute Board of Directors in Tucson,
Arizona and vice chairman of Canyon Ranch. He serves on the boards
of other public companies including The Clorox Company and Taser
International, and works in leadership and advisory roles helping
to create businesses in emerging science and technology.
Born to a poor Hispanic family in New York City, Dr. Carmona
experienced homelessness, hunger, and health disparities during his
youth. The experiences greatly sensitized him to the relationships
among culture, health, education and economic status and shaped his
future.
In 1967, Dr. Carmona enlisted in the U.S. Army and went on to
become a combat-decorated Special Forces Vietnam veteran. After
leaving active duty, he attended Bronx Community College of the
City University of New York, where he received an associate’s
degree. He then attended the University of California, San
Francisco, where he received a bachelor’s degree (1977) and medical
degree (1979).
Trained in general and vascular surgery, Dr. Carmona also
completed a National Institutes of Health-sponsored fellowship in
trauma, burns, and critical care. He went on to become the chairman
of the State of Arizona Southern Regional Emergency Medical System,
a professor of surgery, public health and family and community
medicine at the University of Arizona, and the Pima County
Sheriff's Department surgeon and deputy sheriff.
In 2002, Dr. Carmona was nominated by the President and
unanimously confirmed by the United States Senate to become the
17th Surgeon General of the United States. Dr. Carmona was selected
because of his extensive experience in public health, clinical
sciences, health care management, preparedness, and his commitment
to prevention as an effective means to improve public health and
reduce health care costs while improving the quality and quantity
of life. In 2006, Dr. Carmona successfully completed the statutory
four-year term.
Dr. Carmona has published extensively and received numerous
awards, decorations, and local and national recognitions for his
achievements. A strong supporter of community service, he has
served on community and national boards and provided leadership to
many diverse organizations.
About Herbalife Ltd.
Herbalife Ltd. (NYSE:HLF) is a global nutrition company that
sells weight-management, nutrition and personal care products
intended to support a healthy lifestyle. Herbalife products are
sold in more than 80 countries to and through a network of
independent distributors. The company supports the Herbalife Family
Foundation and its Casa Herbalife program to help bring good
nutrition to children. Herbalife's website contains information
about Herbalife, including financial and other information for
investors at http://ir.Herbalife.com. The company encourages
investors to visit its website from time to time, as information is
updated and new information is posted.
FORWARD-LOOKING STATEMENTS
This document contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of
1934, as amended. All statements other than statements of
historical fact are “forward-looking statements” for purposes of
federal and state securities laws, including any projections of
earnings, revenue or other financial items; any statements of the
plans, strategies and objectives of management for future
operations; any statements concerning proposed new services or
developments; any statements regarding future economic conditions
or performance; any statements of belief; and any statements of
assumptions underlying any of the foregoing. Forward-looking
statements may include the words “may,” “will,” “estimate,”
“intend,” “continue,” “believe,” “expect” or “anticipate” and any
other similar words.
Although we believe that the expectations reflected in any of
our forward-looking statements are reasonable, actual results could
differ materially from those projected or assumed in any of our
forward-looking statements. Our future financial condition and
results of operations, as well as any forward-looking statements,
are subject to change and to inherent risks and uncertainties, such
as those disclosed or incorporated by reference in our filings with
the Securities and Exchange Commission. Important factors that
could cause our actual results, performance and achievements, or
industry results to differ materially from estimates or projections
contained in our forward-looking statements include, among others,
the following:
- the resignation of our former
independent registered public accounting firm, its withdrawal of
its audit reports with respect to certain of our historical
financial statements, any difficulties PricewaterhouseCoopers LLP,
our successor accounting firm encounters in the re-audits of such
relevant historical financial statements or any material
modifications to such historical financial statements
PricewaterhouseCoopers LLP believes should be made as a result of
such re-audits;
- any collateral impact resulting from
the ongoing worldwide financial environment, including the
availability of liquidity to us, our customers and our suppliers or
the willingness of our customers to purchase products in a
difficult economic environment;
- our relationship with, and our ability
to influence the actions of, our distributors;
- improper action by our employees or
distributors in violation of applicable law;
- adverse publicity associated with our
products or network marketing organization, including our ability
to comfort the marketplace and regulators regarding our compliance
with applicable laws;
- changing consumer preferences and
demands;
- our reliance upon, or the loss or
departure of any member of, our senior management team which could
negatively impact our distributor relations and operating
results;
- the competitive nature of our
business;
- regulatory matters governing our
products, including potential governmental or regulatory actions
concerning the safety or efficacy of our products and network
marketing program, including the direct selling market in which we
operate;
- legal challenges to our network
marketing program;
- risks associated with operating
internationally and the effect of economic factors, including
foreign exchange, inflation, disruptions or conflicts with our
third party importers, pricing and currency devaluation risks,
especially in countries such as Venezuela;
- uncertainties relating to the
application of transfer pricing, duties, value added taxes, and
other tax regulations, and changes thereto;
- uncertainties relating to
interpretation and enforcement of legislation in China governing
direct selling;
- uncertainties relating to the
interpretation, enforcement or amendment of legislation in India
governing direct selling;
- our inability to obtain the necessary
licenses to expand our direct selling business in China;
- adverse changes in the Chinese economy,
Chinese legal system or Chinese governmental policies;
- our dependence on increased penetration
of existing markets;
- contractual limitations on our ability
to expand our business;
- our reliance on our information
technology infrastructure and outside manufacturers;
- the sufficiency of trademarks and other
intellectual property rights;
- product concentration;
- changes in tax laws, treaties or
regulations, or their interpretation;
- taxation relating to our
distributors;
- product liability claims;
- whether we will purchase any of our
shares in the open markets or otherwise; and
- share price volatility related to,
among other things, speculative trading and certain traders
shorting our common shares.
We do not undertake any obligation to update or release any
revisions to any forward-looking statement or to report any events
or circumstances after the date hereof or to reflect the occurrence
of unanticipated events, except as required by law.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20131028006558/en/
Herbalife Ltd.Barbara Henderson, SVP, Worldwide Corp.
Communications213-745-0517orAmy Greene, VP, Investor
Relations213-745-0474
Herbalife (NYSE:HLF)
Historical Stock Chart
Von Aug 2024 bis Sep 2024
Herbalife (NYSE:HLF)
Historical Stock Chart
Von Sep 2023 bis Sep 2024